Ravindra Kumar, VP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 16,000 shares at $33.56 ($552K) on 2014-11-12, disclosed to the SEC on 2014-11-14.
Scheduled sale ($552k) by VP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.46 | 1,600 | $52K | 9.4% |
| 2 | $33.56 | 2,400 | $81K | 14.6% |
| 3 | $35.00 | 12,000 | $420K | 76.0% |
| Total | $34.53 avg | 16,000 | $552K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |